Terms: = Skin cancer AND BMPR1A, ACVRLK3, 657, ENSG00000107779, P36894, ALK3, CD292 AND Treatment
30 results:
1. Predictive biomarkers of immunotherapy response with pharmacological applications in solid tumors.
Kovács SA; Fekete JT; Győrffy B
Acta Pharmacol Sin; 2023 Sep; 44(9):1879-1889. PubMed ID: 37055532
[TBL] [Abstract] [Full Text] [Related]
2. Cosmetic Results and Side Effects of Accelerated Partial-Breast Irradiation Versus Whole-Breast Irradiation for Low-Risk Invasive Carcinoma of the Breast: The Randomized Phase III IRMA Trial.
Meduri B; Baldissera A; Iotti C; Scheijmans LJEE; Stam MR; Parisi S; Boersma LJ; Ammendolia I; Koiter E; Valli M; Scandolaro L; Busz D; Stenfert Kroese MC; Ciabatti S; Giacobazzi P; Ruggieri MP; Engelen A; Munafò T; Westenberg AH; Verhoeven K; Vicini R; D'Amico R; Lohr F; Bertoni F; Poortmans P; Frezza GP
J Clin Oncol; 2023 Apr; 41(12):2201-2210. PubMed ID: 36623246
[TBL] [Abstract] [Full Text] [Related]
3. Redefining Perineural Invasion in Head and Neck Cutaneous Squamous Cell Carcinoma.
Cohen ER; Misztal C; Dable C; Gomez-Fernandez C; Bhatia RG; Roth P; Ma R; Trosman S; Green C; Nicolli E; Dinh CT; Sargi ZB
Otolaryngol Head Neck Surg; 2022 Oct; 167(4):705-715. PubMed ID: 35133896
[TBL] [Abstract] [Full Text] [Related]
4. Efficacy and tolerability of vismodegib treatment in locally advanced and metastatic basal cell carcinoma: Retrospective real-life data.
Gürbüz M; Doğan İ; Akkuş E; Ermiş H; Utkan G; Vatansever S; Taş F
Dermatol Ther; 2021 Nov; 34(6):e15122. PubMed ID: 34478210
[TBL] [Abstract] [Full Text] [Related]
5. Evaluation of the modified immune prognostic index to prognosticate outcomes in metastatic uveal melanoma patients treated with immune checkpoint inhibitors.
Sander MS; Stukalin I; Vallerand IA; Goutam S; Ewanchuk BW; Meyers DE; Pabani A; Morris DG; Heng DYC; Cheng T
Cancer Med; 2021 Apr; 10(8):2618-2626. PubMed ID: 33724676
[TBL] [Abstract] [Full Text] [Related]
6. Human osteoarthritis cartilage-derived stromal cells activate joint degeneration through TGF-beta lateral signaling.
Liu W; Feng M; Jayasuriya CT; Peng H; Zhang L; Guan Y; Froehlich JA; Terek RM; Chen Q
FASEB J; 2020 Dec; 34(12):16552-16566. PubMed ID: 33118211
[TBL] [Abstract] [Full Text] [Related]
7. Primary cutaneous melanoma of the scalp: Patterns of clinical, histological and epidemiological characteristics in Brazil.
Porto AC; Pinto Blumetti T; Oliveira Santos Filho IDA; Calsavara VF; Duprat Neto JP; Tavoloni Braga JC
PLoS One; 2020; 15(10):e0240864. PubMed ID: 33095773
[TBL] [Abstract] [Full Text] [Related]
8. What Can Social Media Tell Us About Patient Symptoms: A Text-Mining Approach to Online Ovarian cancer Forum.
Lee YJ; Park A; Roberge M; Donovan H
Cancer Nurs; 2022 Jan-Feb 01; 45(1):E27-E35. PubMed ID: 32649337
[TBL] [Abstract] [Full Text] [Related]
9. ctDNA detected by ddPCR reveals changes in tumour load in metastatic malignant melanoma treated with bevacizumab.
Forthun RB; Hovland R; Schuster C; Puntervoll H; Brodal HP; Namløs HM; Aasheim LB; Meza-Zepeda LA; Gjertsen BT; Knappskog S; Straume O
Sci Rep; 2019 Nov; 9(1):17471. PubMed ID: 31767937
[TBL] [Abstract] [Full Text] [Related]
10. Invasive Melanoma and Melanoma in Situ Treated With Modified Mohs Micrographic Surgery With En Face Permanent Sectioning: A 10-Year Retrospective Review.
Heath M; Woody M; Leitenberger J; Latour E; Bar A
Dermatol Surg; 2020 Aug; 46(8):1004-1013. PubMed ID: 31714384
[TBL] [Abstract] [Full Text] [Related]
11. Baseline clinical and imaging predictors of treatment response and overall survival of patients with metastatic melanoma undergoing immunotherapy.
Schraag A; Klumpp B; Afat S; Gatidis S; Nikolaou K; Eigentler TK; Othman AE
Eur J Radiol; 2019 Dec; 121():108688. PubMed ID: 31704599
[TBL] [Abstract] [Full Text] [Related]
12. Recurrence after sentinel lymph node biopsy in cutaneous melanoma: a single-center experience in Slovak patients.
Sabol M; Reken V; Sabolova L; Waczulikova I; Donat R; Dyttert D; Chvalny P; Durdik S
Neoplasma; 2019 Jul; 66(4):647-651. PubMed ID: 31058535
[TBL] [Abstract] [Full Text] [Related]
13. Steroid Refractory Chronic Graft-Versus-Host Disease: Cost-Effectiveness Analysis.
Yalniz FF; Murad MH; Lee SJ; Pavletic SZ; Khera N; Shah ND; Hashmi SK
Biol Blood Marrow Transplant; 2018 Sep; 24(9):1920-1927. PubMed ID: 29550629
[TBL] [Abstract] [Full Text] [Related]
14. Use of the Hemangioma Severity Scale to facilitate treatment decisions for infantile hemangiomas.
Moyakine AV; Herwegen B; van der Vleuten CJM
J Am Acad Dermatol; 2017 Nov; 77(5):868-873. PubMed ID: 28818436
[TBL] [Abstract] [Full Text] [Related]
15. The Effect of Phototherapy on cancer Predisposition Genes of Diabetic and Normal Human skin Fibroblasts.
Chotikasemsri P; Tangtrakulwanich B; Sangkhathat S
Biomed Res Int; 2017; 2017():7604861. PubMed ID: 28386563
[TBL] [Abstract] [Full Text] [Related]
16. A case of contralateral breast cancer and skin cancer associated with NBN heterozygous pathogenic variant c.698_701delAACA.
Gass J; Jackson J; Macklin S; Blackburn P; Hines S; Atwal PS
Fam Cancer; 2017 Oct; 16(4):551-553. PubMed ID: 28374160
[TBL] [Abstract] [Full Text] [Related]
17. Survival and Surgical Outcomes for Pediatric Head and Neck Melanoma.
Richards MK; Czechowicz J; Goldin AB; Gow KW; Doski J; Goldfarb M; Nuchtern J; Langer M; Beierle EA; Vasudevan S; Gupta D; Parikh SR
JAMA Otolaryngol Head Neck Surg; 2017 Jan; 143(1):34-40. PubMed ID: 27607058
[TBL] [Abstract] [Full Text] [Related]
18. Breast cancer during follow-up and progression - A population based cohort on new cancers and changed biology.
Karlsson E; Appelgren J; Solterbeck A; Bergenheim M; Alvariza V; Bergh J
Eur J Cancer; 2014 Nov; 50(17):2916-24. PubMed ID: 25241230
[TBL] [Abstract] [Full Text] [Related]
19. Adjuvant ganglioside GM2-KLH/QS-21 vaccination versus observation after resection of primary tumor > 1.5 mm in patients with stage II melanoma: results of the EORTC 18961 randomized phase III trial.
Eggermont AM; Suciu S; Rutkowski P; Marsden J; Santinami M; Corrie P; Aamdal S; Ascierto PA; Patel PM; Kruit WH; Bastholt L; Borgognoni L; Bernengo MG; Davidson N; Polders L; Praet M; Spatz A
J Clin Oncol; 2013 Oct; 31(30):3831-7. PubMed ID: 24019551
[TBL] [Abstract] [Full Text] [Related]
20. Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial.
Vermorken JB; Stöhlmacher-Williams J; Davidenko I; Licitra L; Winquist E; Villanueva C; Foa P; Rottey S; Skladowski K; Tahara M; Pai VR; Faivre S; Blajman CR; Forastiere AA; Stein BN; Oliner KS; Pan Z; Bach BA;
Lancet Oncol; 2013 Jul; 14(8):697-710. PubMed ID: 23746666
[TBL] [Abstract] [Full Text] [Related]
[Next]